Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Study of A Selective Estrogen Receptor Modulator vs.-261995000
Cleveland Clinic Lerner, Cleveland, OH, United States
Search grants from Cleveland Clinic Lerner
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
PS10-1001, HIV Prevention Projects
Supporting the Scale-Up High Quality HIV Care and Treatment Programs in Malawi
Nanog-positive cancer stem cells in and liver oncogenesis by alcohol and HCV
River Valley Tobacco and Drug Free Coalition
M-Risp at San Francisco State University
Recently added grants:
Identification of Immunologic Mechanisms of Enhanced Ng Clearance Induced by Nm OMV-based Vaccines
Neisserial OMV Vaccines
Nanodisc-displayed Protein Vaccines
Peptide-VLP Vaccines
Molecular and cellular basis of epidermodysplasia verruciformis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA095000-002
Application #
6688604
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
017730458
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Related projects
NIH 2003
N01 CA
Phase II Clinical Study of A Selective Estrogen Receptor Modulator vs.-261995000
/ Cleveland Clinic Lerner
NIH 2002
N01 CA
Phase II Clinical Study of A Selective Estrogen Receptor Modulator vs.-261995000
/ Cleveland Clinic Lerner
Comments
Be the first to comment on this grant